Wednesday, 9 November 2022

Amyloids binding proteins may beneficial in Alzheimer and Diabetes

Amyloids binding proteins may beneficial in Alzheimer and Diabetes

In Alzheimer's disease, the degeneration of brain cells is linked to formation of toxic protein aggregates and deposits known as amyloid plaques. Similar processes play an important role also in type 2 diabetes. A research team under the lead of the Technical University of Munich has now developed “mini-proteins”, so-called peptides, which are able to bind the proteins that form amyloids and prevent their aggregation into cytotoxic amyloids.

Rajesh Vagh Wed, 11/09/2022 - 17:05

source https://www.pharmatutor.org/pharma-news/2022/amyloids-binding-proteins-may-beneficial-in-alzheimer-and-diabetes

No comments:

Post a Comment

Pharma openings

  Opportunity for M.Pharm, Msc or PhD as Scientist at PGIMER M.Pharmacy or M.Sc 6 Year of Research Experience or PhD with 3 year of Experien...